Cargando…

Determination of a safe sedative combination of dexmedetomidine, ketamine and butorphanol for minor procedures in dogs by use of a stepwise optimization method

BACKGROUND: In veterinary practice, most minor procedures such as radiographs, skin biopsies, and wound treatments require sedation. The combination of butorphanol, ketamine, and dexmedetomidine is commonly used, but the ideal dosages for this combination have not been defined. This randomized prosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Imboden, Tobias Jonas, Pownall, William Robert, Rubin, Stéphanie, Spadavecchia, Claudia, Schöllhorn, Bernhard, Rohrbach, Helene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515426/
https://www.ncbi.nlm.nih.gov/pubmed/37737188
http://dx.doi.org/10.1186/s13028-023-00697-8
_version_ 1785108945712447488
author Imboden, Tobias Jonas
Pownall, William Robert
Rubin, Stéphanie
Spadavecchia, Claudia
Schöllhorn, Bernhard
Rohrbach, Helene
author_facet Imboden, Tobias Jonas
Pownall, William Robert
Rubin, Stéphanie
Spadavecchia, Claudia
Schöllhorn, Bernhard
Rohrbach, Helene
author_sort Imboden, Tobias Jonas
collection PubMed
description BACKGROUND: In veterinary practice, most minor procedures such as radiographs, skin biopsies, and wound treatments require sedation. The combination of butorphanol, ketamine, and dexmedetomidine is commonly used, but the ideal dosages for this combination have not been defined. This randomized prospective clinical 3-phases trial initially tested eight clinically relevant combinations of intramuscular administration in 50 dogs (phase 1). The quality of each combination was rated using a purposefully developed negative score (NS; 0-21.5, the lower the NS the better the quality of sedation) to judge the quality of sedation, the occurrence of side effects, and the need for additional anaesthetics. Based on the results of the NS, the eight combinations were divided into “promising” and “unsatisfactory” subgroups. In phase 2, a new combination (N) was calculated and tested in six dogs replacing the worst of the eight initial combinations. This procedure was repeated until the NS could not be improved any further. In phase 3, the best combination was tested in 100 adult dogs undergoing diagnostic or therapeutic procedures. RESULTS: The optimal combination established was dexmedetomidine 0.005 mg/kg, ketamine 1 mg/kg, and butorphanol 0.3 mg/kg with a median NS of 1.5 (interquartile range 1.5–2.4). In all 112 dogs receiving this combination, the quality of sedation was satisfactory and no severe side effects were detected. CONCLUSIONS: The application of this optimization method allowed the calculation of an optimal drug combination to sedate cardiovascularly healthy dogs. After having being tested in 112 animals, this combination can consequently be considered safe. Therefore, this combination can now be used in daily clinical practice for cardiovascularly healthy adult dogs undergoing minor procedures. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13028-023-00697-8.
format Online
Article
Text
id pubmed-10515426
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105154262023-09-23 Determination of a safe sedative combination of dexmedetomidine, ketamine and butorphanol for minor procedures in dogs by use of a stepwise optimization method Imboden, Tobias Jonas Pownall, William Robert Rubin, Stéphanie Spadavecchia, Claudia Schöllhorn, Bernhard Rohrbach, Helene Acta Vet Scand Research BACKGROUND: In veterinary practice, most minor procedures such as radiographs, skin biopsies, and wound treatments require sedation. The combination of butorphanol, ketamine, and dexmedetomidine is commonly used, but the ideal dosages for this combination have not been defined. This randomized prospective clinical 3-phases trial initially tested eight clinically relevant combinations of intramuscular administration in 50 dogs (phase 1). The quality of each combination was rated using a purposefully developed negative score (NS; 0-21.5, the lower the NS the better the quality of sedation) to judge the quality of sedation, the occurrence of side effects, and the need for additional anaesthetics. Based on the results of the NS, the eight combinations were divided into “promising” and “unsatisfactory” subgroups. In phase 2, a new combination (N) was calculated and tested in six dogs replacing the worst of the eight initial combinations. This procedure was repeated until the NS could not be improved any further. In phase 3, the best combination was tested in 100 adult dogs undergoing diagnostic or therapeutic procedures. RESULTS: The optimal combination established was dexmedetomidine 0.005 mg/kg, ketamine 1 mg/kg, and butorphanol 0.3 mg/kg with a median NS of 1.5 (interquartile range 1.5–2.4). In all 112 dogs receiving this combination, the quality of sedation was satisfactory and no severe side effects were detected. CONCLUSIONS: The application of this optimization method allowed the calculation of an optimal drug combination to sedate cardiovascularly healthy dogs. After having being tested in 112 animals, this combination can consequently be considered safe. Therefore, this combination can now be used in daily clinical practice for cardiovascularly healthy adult dogs undergoing minor procedures. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13028-023-00697-8. BioMed Central 2023-09-22 /pmc/articles/PMC10515426/ /pubmed/37737188 http://dx.doi.org/10.1186/s13028-023-00697-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Imboden, Tobias Jonas
Pownall, William Robert
Rubin, Stéphanie
Spadavecchia, Claudia
Schöllhorn, Bernhard
Rohrbach, Helene
Determination of a safe sedative combination of dexmedetomidine, ketamine and butorphanol for minor procedures in dogs by use of a stepwise optimization method
title Determination of a safe sedative combination of dexmedetomidine, ketamine and butorphanol for minor procedures in dogs by use of a stepwise optimization method
title_full Determination of a safe sedative combination of dexmedetomidine, ketamine and butorphanol for minor procedures in dogs by use of a stepwise optimization method
title_fullStr Determination of a safe sedative combination of dexmedetomidine, ketamine and butorphanol for minor procedures in dogs by use of a stepwise optimization method
title_full_unstemmed Determination of a safe sedative combination of dexmedetomidine, ketamine and butorphanol for minor procedures in dogs by use of a stepwise optimization method
title_short Determination of a safe sedative combination of dexmedetomidine, ketamine and butorphanol for minor procedures in dogs by use of a stepwise optimization method
title_sort determination of a safe sedative combination of dexmedetomidine, ketamine and butorphanol for minor procedures in dogs by use of a stepwise optimization method
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515426/
https://www.ncbi.nlm.nih.gov/pubmed/37737188
http://dx.doi.org/10.1186/s13028-023-00697-8
work_keys_str_mv AT imbodentobiasjonas determinationofasafesedativecombinationofdexmedetomidineketamineandbutorphanolforminorproceduresindogsbyuseofastepwiseoptimizationmethod
AT pownallwilliamrobert determinationofasafesedativecombinationofdexmedetomidineketamineandbutorphanolforminorproceduresindogsbyuseofastepwiseoptimizationmethod
AT rubinstephanie determinationofasafesedativecombinationofdexmedetomidineketamineandbutorphanolforminorproceduresindogsbyuseofastepwiseoptimizationmethod
AT spadavecchiaclaudia determinationofasafesedativecombinationofdexmedetomidineketamineandbutorphanolforminorproceduresindogsbyuseofastepwiseoptimizationmethod
AT schollhornbernhard determinationofasafesedativecombinationofdexmedetomidineketamineandbutorphanolforminorproceduresindogsbyuseofastepwiseoptimizationmethod
AT rohrbachhelene determinationofasafesedativecombinationofdexmedetomidineketamineandbutorphanolforminorproceduresindogsbyuseofastepwiseoptimizationmethod